RO.CH

284.8

+0.07%↑

NOVN.CH

102.06

-0.06%↓

LONN.CH

567

-0.18%↓

BANB.CH

62.05

-1.66%↓

RO.CH

284.8

+0.07%↑

NOVN.CH

102.06

-0.06%↓

LONN.CH

567

-0.18%↓

BANB.CH

62.05

-1.66%↓

RO.CH

284.8

+0.07%↑

NOVN.CH

102.06

-0.06%↓

LONN.CH

567

-0.18%↓

BANB.CH

62.05

-1.66%↓

RO.CH

284.8

+0.07%↑

NOVN.CH

102.06

-0.06%↓

LONN.CH

567

-0.18%↓

BANB.CH

62.05

-1.66%↓

RO.CH

284.8

+0.07%↑

NOVN.CH

102.06

-0.06%↓

LONN.CH

567

-0.18%↓

BANB.CH

62.05

-1.66%↓

Search

Straumann Holding AG

Gesloten

SectorGezondheidszorg

93.98 -1.41

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

93.86

Max

95.72

Belangrijke statistieken

By Trading Economics

Inkomsten

191M

Verkoop

1.2B

K/W

Sectorgemiddelde

35.309

35.733

EPS

1.66

Dividendrendement

1.01

Winstmarge

15.499

Werknemers

11,948

EBITDA

416M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+37.14% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.01%

3.13%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

15B

Vorige openingsprijs

95.39

Vorige sluitingsprijs

93.98

Nieuwssentiment

By Acuity

50%

50%

173 / 371 Rangschikking in Healthcare

Straumann Holding AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 apr 2025, 08:20 UTC

Marktinformatie

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Peer Vergelijking

Prijswijziging

Straumann Holding AG Prognose

Koersdoel

By TipRanks

37.14% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 130.2 CHF  37.14%

Hoogste 150 CHF

Laagste 103 CHF

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Straumann Holding AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

6

Buy

4

Hold

1

Sell

Sentiment

By Acuity

173 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Straumann Holding AG

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
help-icon Live chat